USA Uranium Elects New Directors, Evaluates Transactions

LAS VEGAS--(BUSINESS WIRE)--USA Uranium (OTCBB: USAUE) is pleased to announce that Mr. James C. Katzaroff has joined the Board of Directors and agreed to serve as head of the Board’s project acquisition committee. Mr. Katzaroff will be reviewing and advising the Company in areas related to biometric security, medical projects as well as advanced cellular communications applications.

Mr. Katzaroff is the founder of Advanced Medical Isotope Corporation and holds the positions of Chairman of the Board and Chief Executive Officer. Advanced Medical Isotope Corporation is a publically listed Company (Pink Sheets: ADMD) engaged in the production and distribution of medical isotopes and medical isotope technologies. The AMIC production center utilizes a proton linear accelerator (PULSAR®) manufactured by AccSys Technology, Inc. a Hitachi Company. AMIC utilizes this compact isotope production system as their core differentiated technology in their Kennewick, Washington production facility.

Initially a financial consultant with Wall Street firms Bateman Eichler, Smith Barney and EF Hutton, Mr. Katzaroff has been responsible for senior-level corporate strategy, fostering investment banking relationships, and served as a senior financial advisor for numerous start-ups and development-stage companies. From 1998 to 2001, Mr. Katzaroff held senior positions including CFO, Senior Vice President of Finance, and Senior Vice President, of Telemac Corporation, an international communications company in the wireless telephony market. In 2001 he became Chairman and CEO of Apogee Biometrics, and in 2004 became President of Manakoa Services Corporation, currently serving as its interim CEO. He holds a Bachelor’s Degree in Business Economics from the University of California, Santa Barbara, and has completed advanced management courses at the University of Washington.

Additionally, Mr. Jose Alfred (Fred) Chavallo, will also be joining the Board of Directors replacing Dr. Earl Abbott, who resigned to pursue other business ventures. Mr. Chavallo is a real estate investor and developer specializing in the design, development and construction of luxury residential and professional office buildings. Mr. Chavallo has also been a financier and investor in several high tech projects in the security, medical and environmental industries.

Given current economic conditions, and pending Mr. Katzaroff’s review and evaluation, the Company will be holding in abeyance the previously announced transaction with MyScreenMd.com. Accordingly, there will be no changes to the Company’s name and web site until completion of the evaluation.